Ampersand Capital Partners

Lexington Medical, Inc., founded in 2013 and based in Watertown, Massachusetts, specializes in the development and manufacture of medical devices, particularly minimally invasive surgical stapling solutions. The company focuses on creating innovative surgical instruments that enhance hemostatic stapling across various procedures, such as cholecystectomy, bariatric surgery, colectomy, appendectomy, and hysterectomy. By prioritizing high standards in design engineering and smart manufacturing, Lexington Medical aims to improve the efficiency of surgical operations, thereby providing health care providers and their patients with reliable outcomes.

VIVEbiotech specializes in the development and manufacturing of lentiviral vectors, adhering to regulatory guidelines set by the EMA and FDA. The company provides contract development and manufacturing services tailored to meet the specific needs of its clients. VIVEbiotech's lentiviral vectors are employed in the treatment of various conditions, including hematological cancers, solid tumors, and rare diseases. By offering personalized services that include vector design and cloning tools, VIVEbiotech supports clients in conducting tests and research related to these challenging health issues.

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of monoclonal antibodies in clinical trials for the treatment and diagnosis of cancer. The Company has two platforms and are pursuing multiple clinical programs in cancer with its lead immunotherapy candidate bavituximab, its PS-targeting agent, 124I-PGN650 (PGN650), and its brain cancer therapy Cotara. Bavituximab is the Company’s therapeutic PS-targeting antibody. PGN650 is its PS-targeting imaging agent. The Company has conducted three randomized Phase II trials for bavituximab in combination with standard chemotherapy in both front and second-line NSCLC as well as front-line pancreatic cancer. In addition, it has four ongoing ISTs evaluating bavituximab with additional drug combinations in additional oncology indications

Nektar Therapeutics is a biopharmaceutical company based in San Francisco, California, with additional operations in Huntsville, Alabama, and Hyderabad, India. The company focuses on researching and developing investigational drugs for oncology, immunology, and virology, alongside a portfolio of partnered approved medicines. Its clinical pipeline includes notable candidates such as NKTR-181 for chronic low back pain, ONZEALD for advanced metastatic breast cancer, and Bempegaldesleukin, designed to enhance cancer-killing T cell activity. Nektar is also developing therapies for autoimmune diseases, including NKTR-358, and various other conditions like hemophilia A, opioid-induced constipation, and systemic lupus erythematosus. The company's strategy involves leveraging the immune system to combat cancer and restore immune balance in autoimmune disorders. Nektar has established collaboration agreements with several major pharmaceutical companies, enhancing its research capabilities and development efforts. Incorporated in 1990, Nektar Therapeutics continues to advance its innovative drug candidates through various stages of clinical trials.

Biologos, LLC, established in 1976 and headquartered in Montgomery, Illinois, specializes in the manufacturing of sterile filtered and irradiated solutions, including sera, enzyme solutions, and balanced salt solutions. The company provides a range of products, such as standard and custom cell culture media and reagents, which are essential for supporting cell growth in artificial environments. Biologos has built a reputation as a trusted provider of biological solutions, having shipped over 7 million liters of product globally and serving more than 200 tissue banks and leading animal health companies in the United States. The firm's commitment to quality and rapid product formulation and distribution has positioned it as a significant contributor to advancements in health and wellness.

Specac is a manufacturer of spectroscopic accessories that serves various industries, including forensic, life sciences, pharmaceuticals, research, and quality control. Established in 1954, the company specializes in providing reliable infrared (IR) and Fourier-transform infrared (FTIR) sample handling accessories, which are essential for accurate molecular analysis. Specac's product offerings include spectrometers, kits, wire grid polarizers, reflectance and microscopy accessories, transmission windows, and hydraulic presses, along with consumables and spare parts for atomic and molecular spectroscopy. Over the years, Specac has built a strong reputation for innovation, continuously adapting to the evolving needs of its global customer base in academic and industrial sectors. The company has undergone several transformations, including its founding as Research & Industrial Instruments and subsequent rebranding to Specac, reflecting its commitment to advancing spectroscopic technologies. Today, Specac is recognized as a leader in the development of FTIR sample handling accessories, supported by a robust international distribution network.

Julius Clinical specializes in distinct therapeutic areas that offer a full-service proposal or separate functional service.

Vernal Biosciences is an mRNA manufacturing company that offers high-purity mRNA for both research and clinical applications. The company utilizes advanced processing and analytical methods to streamline the manufacturing process, significantly reducing development cycles typical in the advanced therapeutics sector. By providing high-quality mRNA and lipid nanoparticles (LNP-mRNA), Vernal Biosciences enables researchers to conduct drug discovery and development with flexibility, minimizing the need for substantial investment in proprietary teams and facilities. Its services cater to a wide range of mRNA-based life science needs, supporting both animal and human applications.

NanoImaging Services, Inc. specializes in transmission electron microscopy (TEM) imaging and analysis, catering to the pharmaceutical, biotechnology, and nanotechnology sectors. Founded in 2007 and based in San Diego, California, the company offers a range of services including sizing and counting, characterization of sub-micron aggregates, liposomes, emulsions, proteins, and viruses, as well as 3D structure determination. With state-of-the-art facilities equipped with advanced electron microscopes and computational infrastructure, NanoImaging Services focuses on providing direct visualization of biological molecules in their native hydrated state, essential for the development of vaccines, antibodies, and gene therapies. The organization is recognized for its expertise and reliability, and is committed to expanding its capabilities through new acquisitions and the development of innovative service offerings, making it a leading provider of TEM and cryo-electron microscopy services in the industrial life science market.

Iuvo is a contract research organization that provides preclinical testing, clinical research, and consulting services to the healthcare sector.

AcuraBio is a contract development and manufacturing organization that specializes in providing services to the pharmaceutical, biotechnology, and veterinary sectors. The company offers a range of products, including recombinant proteins, vaccines, and complex live biotherapeutic products. By focusing on quality, cost-effectiveness, and intellectual property assurances, AcuraBio supports its clients in the development and market introduction of innovative therapeutics.

Phosphorex is a leading contract development and manufacturing organization (CDMO) specializing in sustained release formulation, nanomedicine and delivery of nucleic acids. Since 2005, Phosphorex has been partnering with the biomedical community to develop a variety of microparticles, nanoparticles and particle-based pharmaceutical formulations.

Sterling Medical Devices is a custom electro-mechanical and software solution provider for the medical device industry.

AnaBios is a contract research organization (CRO) focused on enhancing drug discovery through human-centric methodologies. The company offers a range of products and services that cover all phases of drug development, utilizing proprietary technology that leverages human donor organs and tissues. This approach allows AnaBios to investigate ex vivo human responses to drugs, providing insights into the molecular and functional aspects of human physiology. The research primarily targets significant unmet medical needs in areas such as cardiac disease, pain management, polycystic kidney disease, and neurodegeneration. By collaborating with pharmaceutical companies, contract research organizations, and academic institutions, AnaBios aims to generate predictive human data that improves the selection of effective and safe drugs, ultimately reducing costs and time associated with clinical trial failures while advancing therapeutic solutions to enhance patient health and quality of life.

Vernal Biosciences is an mRNA manufacturing company that offers high-purity mRNA for both research and clinical applications. The company utilizes advanced processing and analytical methods to streamline the manufacturing process, significantly reducing development cycles typical in the advanced therapeutics sector. By providing high-quality mRNA and lipid nanoparticles (LNP-mRNA), Vernal Biosciences enables researchers to conduct drug discovery and development with flexibility, minimizing the need for substantial investment in proprietary teams and facilities. Its services cater to a wide range of mRNA-based life science needs, supporting both animal and human applications.

Syft Technologies Ltd. specializes in the development and support of advanced air analysis solutions, primarily focusing on detecting and quantifying trace amounts of volatile organic compounds (VOCs). The company's flagship product, the Voice200 SIFT-MS instrument, allows users to simultaneously identify and measure a wide range of gaseous chemicals. Additionally, Syft offers a Sample Collection Case for compact and portable sample collection, as well as a Sample Bag Flushing Station for cleaning sample bags. Their analytical solutions serve diverse sectors, including environmental monitoring, food and fragrance analysis, medical research, and oil and gas exploration. Syft Technologies distributes its products through a network of partners across Europe and maintains operations in Christchurch, New Zealand; Warrington, UK; and Pittsburgh, Pennsylvania. Founded in 2002, the company is committed to providing innovative gas analysis technology that enhances air quality monitoring and improves research capabilities.

BioEcho Life Sciences specializes in the development and production of advanced technologies for molecular biology and diagnostics. The company focuses on manufacturing nucleic acid purification products designed to enhance laboratory workflows in a more convenient, robust, and sustainable manner. Utilizing a proprietary single-step purification technology, BioEcho offers innovative sample lysis and purification tools that facilitate rapid and high-quality extraction of nucleic acids. These tools serve a variety of sectors, including clinical diagnostics, biotechnology, agricultural, and industrial applications. By streamlining DNA and RNA extraction processes, BioEcho aims to improve efficiency compared to traditional methods, while also reducing inhibitors that can affect downstream PCR and sequencing applications.

ProtaGene is an analytic service provider across the biopharmaceutical, cell, and gene therapy development spaces. They provide complete protein and gene analytic capabilities and packages for biologic therapeutics as well as cell and gene therapy platforms. They offer product testing and analytical packages for product lifecycle management.

Magritek Limited specializes in the design and manufacture of benchtop nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) systems. Founded in 2004 and based in Wellington, New Zealand, with an additional office in Aachen, Germany, Magritek provides innovative, cryogen-free instruments for a variety of applications, including oil and gas, research, education, and portable markets. Their product offerings include ultra-compact NMR spectrometers for chemistry education, NMR rock core analyzers for hydrocarbon reservoir analysis, and portable NMR sensors known as NMR-MOUSE. The company also delivers systems such as Kea for research, a compact tomography system, and software for processing multi-dimensional NMR data. Magritek's solutions cater to industries such as pharmaceuticals, polymers, food, and petrochemicals, ensuring access to efficient and affordable analytical instruments for laboratories worldwide. The company serves its customers through a network of distributors.

Arranta Bio LLC is a contract development and manufacturing organization based in Watertown, Massachusetts, with a facility in Gainesville, Florida. Founded in 2019, the company specializes in the development and manufacturing of live biopharmaceutical products, particularly live biotherapeutic products (LBPs) aimed at addressing diseases related to the human microbiome. Arranta Bio offers a range of services, including media formulation, cell banking, fermentation, lyophilization, and drug product finishing, all compliant with cGMP standards. Additionally, the company provides analytical services to support its clients in the healthcare sector. By focusing on bacterial fermentation and encapsulation techniques, Arranta Bio enables innovators to develop effective therapies for clinical and commercial use.

GeneWerk GmbH is a specialized testing laboratory focused on cell and gene therapy, offering a range of preclinical and clinical trial patient sample analysis services. Founded in July 2014 by a team of experts including Prof. Dr. Christof von Kalle, the company is based in Heidelberg, Germany, and has strong ties to the German Cancer Research Center. GeneWerk provides various analytical products, including Vector Safety for viral vector integration site analysis, AAV vector quality control, immune repertoire analysis, qPCR, and gene editing on- and off-target analyses. The laboratory is committed to developing innovative analysis methods and ensures compliance with guidelines from regulatory bodies such as the U.S. Food and Drug Administration and the European Medicines Agency.

ALPCO Diagnostics is a manufacturer of immunoassay-based products that caters to both the life science research and clinical diagnostic sectors. The company specializes in developing a variety of specialty immunoassay products, including In Vitro Diagnostics (IVDs) and Research Use Only (RUO) tests. These products are designed to aid in the investigation, detection, diagnosis, and treatment of health-related disorders and diseases. By providing scientists and healthcare professionals with essential testing solutions, ALPCO Diagnostics supports advancements in research and enhances patient care outcomes.

Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

Arranta Bio LLC is a contract development and manufacturing organization based in Watertown, Massachusetts, with a facility in Gainesville, Florida. Founded in 2019, the company specializes in the development and manufacturing of live biopharmaceutical products, particularly live biotherapeutic products (LBPs) aimed at addressing diseases related to the human microbiome. Arranta Bio offers a range of services, including media formulation, cell banking, fermentation, lyophilization, and drug product finishing, all compliant with cGMP standards. Additionally, the company provides analytical services to support its clients in the healthcare sector. By focusing on bacterial fermentation and encapsulation techniques, Arranta Bio enables innovators to develop effective therapies for clinical and commercial use.

New England Peptide, Inc. specializes in the design and manufacture of a wide range of peptides and related products. Its offerings include bioactive peptides, amino acids, phospho amino acids, pseudoprolines, and heavy amino acids, as well as peptide synthesis accessories and stable isotope standard tryptic peptides for protein identification. The company also provides custom polyclonal and monoclonal antibodies, along with analytical services such as amino acid analysis, liquid chromatography/mass spectrometry, sequencing, and sample preparation. Catering primarily to organizations involved in drug and vaccine discovery, New England Peptide sells products online and through distributors in Japan, Taiwan, and Korea. Founded in 1998 and headquartered in Harvard, Massachusetts, the company maintains an additional office in Cambridge, Massachusetts.

Vivitide is a manufacturer focused on producing peptides and polyclonal antibodies, catering to organizations involved in drug, vaccine, and diagnostic development. The company offers a range of services, including custom peptide synthesis and antibody packages, available for both small and large-scale industries. Its product offerings encompass peptide arrays, catalog peptides, novel amino acids, amino acid derivatives, and resins, which are utilized in the treatment of various conditions such as cancer, diabetes, obesity, infections, and HIV. By providing high-quality and tailored solutions, Vivitide supports its clients in advancing their biomedical research and therapeutic applications.

Interpace Biosciences is a leader in the life sciences sector, specializing in complex molecular analysis to facilitate the early diagnosis and treatment of cancer. The company operates through its Interpace Diagnostics business unit, which offers clinically beneficial molecular diagnostic tests and pathology services. Among its notable products are PancraGen, ThyGeNext, ThyraMir, RespriDX, and BarreGen, all designed to evaluate cancer risk and guide personalized treatment strategies. Interpace Biosciences utilizes advanced technology in personalized medicine, focusing on genomic tests aimed at early detection for patients with indeterminate biopsy results or those at high risk for cancer. Through its comprehensive approach, the company plays a critical role in enhancing patient diagnosis and management in oncology.

N2 Biomedical specializes in coating and surface treatment services for the medical device industry, focusing on products such as guidewires, core wires, hypo tubes, and forming mandrels. The company collaborates closely with healthcare and medical device manufacturers to provide a comprehensive range of services, from concept development to commercialization. N2 Biomedical offers flexible prototype work, as well as high-volume coating, finishing, and printing services. Its advanced coatings enhance the material characteristics of implantable and other medical devices, improving properties such as wear resistance, corrosion resistance, fracture toughness, lubricity, infection resistance, biocompatibility, aesthetics, and radiopacity. This enables clients in various healthcare sectors, including orthopedic and cardiovascular, to meet critical performance standards for their products.

Genome Diagnostics B.V., known as GenDx, specializes in developing and marketing in vitro diagnostic (IVD) tests, analysis software, and educational resources, with a focus on sequencing-based typing (SBT) for transplantation. Founded in 2005 and based in Utrecht, the Netherlands, GenDx offers a range of products, including optimized reagents for Sanger SBT, high-throughput typing reagents, and software solutions for HLA analysis. Their product lineup features tools such as SBTexcellerator, SBTengine, NGSgo Full Workflow, and Chimerism Monitoring, which facilitate both Sanger and next-generation sequencing methods. The company also provides laboratory services and partners with organizations like Linkage Biosciences, Kyratec, and QIAGEN to enhance its offerings. GenDx distributes its products directly and through specialized distributors in the HLA field.

Canopy Biosciences is a biotechnology company specializing in research tools for gene editing, molecular biology, and personalized medicine. Founded in 2016 and headquartered in St. Louis, Missouri, the company offers a range of products and services designed to enhance scientific discovery in biomedical research. Its gene editing technology, known as TUNR, facilitates targeted modifications in the genome by inserting polyA tracks into specific coding regions, which reduces mRNA levels and subsequently suppresses protein expression. This innovative approach supports researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, advancing the fields of genetic engineering and gene expression analysis. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

NEOMED-LABS is a provider of clinical immunology laboratory services for biologics drug development. NEOMED-LABS is an independent, pure player in the immunology field whose team of experts and state of the art BSL2 labs were instrumental in the development, qualification, and validation of more than 30 assays supporting the FDA filing of 10 marketed vaccines whose cumulative sales is around $3bn. Our unrivaled expertise in immunotools engineering and stability testing, as well as our capacity of 200k results per year on our immunochemistry, virology, and bacteriology automated platforms are devoted to personalized services and fast track method validation.

MedPharm Ltd. is a leading provider of pharmaceutical research and development services specializing in topical and transdermal products. Founded in 1999 and headquartered in Guildford, United Kingdom, with an additional office in Durham, North Carolina, the company focuses on formulating products for dermatological, nail, eye, airway, and mucosal membrane applications. MedPharm offers a comprehensive range of services, including target product profiling, bio-analysis, formulation optimization, and performance testing, utilizing advanced drug delivery technologies such as MedSpray. The company aims to minimize risks and accelerate development times for both generic and proprietary pharmaceutical clients by employing cost-effective performance testing models recognized for their scientific rigor. MedPharm serves a global clientele spanning the United States, Europe, Australia, Japan, India, South Korea, the Middle East, and China, establishing itself as a key player in the pharmaceutical sector.

Nexcelom Bioscience LLC is a biotechnology company specializing in the development and marketing of image cytometry products focused on cell analysis for life science and biomedical research. Established in 2003 and based in Lawrence, Massachusetts, Nexcelom offers a range of products including the Cellometer, which uses bright field and fluorescence imaging modes to count and analyze cell lines and primary cells, and the Celigo, a high-throughput image cytometry system designed for both adherent and suspension cells in microwell plates. In addition to these instruments, the company provides fluorescent reagents and kits for cell counting and cell-based assays, catering to various research fields such as immuno-oncology, cell therapy, drug discovery, vaccine development, and therapeutic cell line generation.

Detector Technology, Inc. is a world-class leading manufacturer of products and systems for OEM and equipment manufacturers. DeTech specializes in Channel Electron Multipliers, Glass Extrusion & Fabrication and Motion Control Products. With a state of the art fabrication and production facility, our dedicated team has been delivering excellence in manufacturing and customer satisfaction over the last 20 years.

Adaptas Solutions is a strategic original equipment manufacturer (OEM) that specializes in providing contract manufacturing services for analytical and laboratory equipment. The company focuses on developing critical components and subsystems for gas chromatography, mass spectrometry, and liquid chromatography applications. Its product offerings include electron multipliers, filaments, power supplies, and ion optic grids, as well as components for liquid handling and lab automation. By supplying high-quality products, Adaptas Solutions enables manufacturers of analytical and laboratory equipment to enhance their production processes and meet the demands of their respective markets.

LakePharma is a contract research organization (CRO) specializing in antibody and protein engineering, cell line development, and protein production. The company's range of services covering areas such as antibody engineering, antibody discovery, molecular engineering, protein chemistry, bioexpression, biofunction, bioprocessing and bioanalytics focus on integrated platforms to support projects throughout the drug discovery process and offers dedicated client services and sophisticated software to provide real-time access to project data via a secure cloud-based portal enabling clients to accelerate product development from lead discovery to Phase 1 clinical trials. Located in the heart of the San Francisco Bay Area, LakePharma has developed numerous in-house technology platforms to provide cost-effective and high quality services to its customers. The production processes are SOP-based and high-throughput, and have been streamlined to be exceptionally efficient on both a small and large scale. Each project is actively managed by a dedicated study director to ensure timely completion with superior results and transparent communication. Clients have real-time access to their project data and can view and receive status updates through LakePharma’s secure cloud-based Datasystems. LakePharma follows the principles of Good Laboratory Practices (GLP) to ensure the quality, reliability and integrity of study data. Upon request, services can also be performed in full compliance with FDA documentation requirements for submissions for nonclinical laboratory studies. All services are provided solely on a fee-for-service basis and are royalty-free.

CORPUS MEDICAL INC. provides top-notch consulting services for the medical device industry. We have extensive experience in developing a wide array of medical devices, we work fast and smart and we are passionate about what we do. From concept to market, let us be your partner.

Canopy Biosciences is a biotechnology company specializing in research tools for gene editing, molecular biology, and personalized medicine. Founded in 2016 and headquartered in St. Louis, Missouri, the company offers a range of products and services designed to enhance scientific discovery in biomedical research. Its gene editing technology, known as TUNR, facilitates targeted modifications in the genome by inserting polyA tracks into specific coding regions, which reduces mRNA levels and subsequently suppresses protein expression. This innovative approach supports researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, advancing the fields of genetic engineering and gene expression analysis. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

Canopy Biosciences is a biotechnology company specializing in research tools for gene editing, molecular biology, and personalized medicine. Founded in 2016 and headquartered in St. Louis, Missouri, the company offers a range of products and services designed to enhance scientific discovery in biomedical research. Its gene editing technology, known as TUNR, facilitates targeted modifications in the genome by inserting polyA tracks into specific coding regions, which reduces mRNA levels and subsequently suppresses protein expression. This innovative approach supports researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, advancing the fields of genetic engineering and gene expression analysis. Canopy Biosciences operates as a subsidiary of Bruker Corporation.

Brammer Bio is a contract development and manufacturing organization (CDMO) serving companies seeking to develop and commercialize cell and gene therapies. With an experienced management team and exceptional scientific expertise and proven manufacturing capabilities we offer the knowledge and resources necessary to help you deliver innovative cell and gene-based therapies. Brammer Bio is focused on providing clinical and commercial supply of autologous and allogeneic cell therapies, and viral vector products for in vivo and ex vivo therapeutic applications. Along with process and analytical development and regulatory support we enable large pharma and biotech clients to accelerate the delivery of novel medicines and improve patient health. Brammer Bio occupies 45,000 ft2 of process development and phase I/II clinical manufacturing space in Alachua, FL, and is developing a 50,000 ft2 facility in Lexington, MA, with plans to build-out large-scale, phase III/commercial ready viral vector manufacturing suites, segregated cell and gene therapy suites, and QC and analytical laboratories for clinical and commercial launch services.

Avista Pharma Solutions is a contract testing, development and manufacturing organization encompassing over 200,000 square feet of laboratory and manufacturing space across three locations (Agawam, MA, Durham, NC, and Longmont, CO), providing pharmaceutical, animal health and medical device clients with a broad suite of scientifically-differentiated services ranging from early drug development to drug product manufacturing.

Gyros Protein Technologies AB is a Swedish company specializing in solutions for peptide synthesis and bioanalysis, aimed at enhancing biomolecule performance and productivity in various scientific fields. Founded in 2016 and headquartered in Uppsala, the company offers a range of peptide synthesizer platforms, including PurePep Chorus, Tribute, Prelude X, Symphony X, and Sonata, which provide high purity and flexibility for the synthesis of peptides. Additionally, Gyros Protein Technologies develops proprietary nanoliter-scale immunoassay platforms, such as Gyrolab xPand and Gyrolab xP workstation, utilized by professionals in pharmaceutical, biotechnology, contract research, and contract manufacturing sectors for bioanalytical applications. These technologies support critical processes such as pharmacokinetics, immunogenicity assessments, and the quantification of bioprocess-related impurities. By offering advanced tools for peptide synthesis and bioanalysis, Gyros Protein Technologies accelerates the discovery, development, and manufacturing of biotherapeutics. It operates as a subsidiary of Mesa Laboratories, Inc.

GENEWIZ, Inc. is a global contract research organization specializing in genomics and DNA sequencing services tailored for pharmaceutical, biotechnology, academic, agricultural, and government sectors. Founded in 1999 and headquartered in South Plainfield, New Jersey, GENEWIZ offers a comprehensive range of services including Sanger DNA Sequencing, gene synthesis, molecular biology applications, next-generation sequencing, and custom bioinformatics. The company is also equipped to provide regulatory-compliant laboratory services for FDA applications, such as RNA/DNA identity studies and single nucleotide polymorphism testing. With a focus on delivering high-quality data and robust technical support, GENEWIZ aims to enhance productivity in scientific research and facilitate advancements in translational medicine and healthcare. The organization operates multiple locations across the United States and internationally in countries including China, the United Kingdom, France, and Japan. As of November 2018, GENEWIZ functions as a subsidiary of Brooks Automation, Inc.

Azurity Pharmaceuticals is a pharmaceutical company focused on developing and marketing drug products to meet the needs of patients with specific medical conditions. The company specializes in creating oral liquid medications, which cater to individuals such as children and elderly patients who may have difficulty swallowing traditional pills or tablets. Its product portfolio includes treatments for conditions like attention deficit hyperactivity disorder (ADHD), hypertension, and congestive heart failure, as well as antimicrobial treatments and mouthwashes. By providing innovative alternatives to traditionally compounded medications, Azurity Pharmaceuticals aims to improve patient care and address unmet medical needs.

Elite One Source Nutritional Services, Inc., based in Missoula, Montana, specializes in contract manufacturing services for nutritional and dietary supplements. Established in 2013, the company has developed a reputation for producing a wide range of health-focused products. As of February 2018, it operates as a subsidiary of DCC Health & Beauty Solutions Limited, allowing it to leverage additional resources and expertise in the health and beauty sector. Through its commitment to quality and innovation, Elite One Source aims to meet the diverse needs of its clients in the nutritional supplement industry.

Sanova Dermatology, based in Austin, Texas, is a comprehensive dermatology center that provides both cosmetic and medical skin care services. The clinic specializes in various treatments, including wrinkle reduction, acne management, and skin cancer care. Their offerings encompass medical dermatology, surgical procedures such as Mohs micrographic surgery, and aesthetic treatments like laser procedures, dermal fillers, and Botox. With a focus on individualized care, Sanova Dermatology aims to address the unique aesthetic and medical needs of each patient through a team of experienced professionals.

Willow Laboratories is a multifaceted company specializing in cannabis packaging and clinical laboratory services. The firm offers packaging solutions tailored for craft cannabis, as well as extract and formulation services. In addition to its cannabis-related operations, Willow Laboratories provides clinical and forensic toxicology laboratory services, including urine, hair, and saliva testing. These services cater to a diverse clientele, including healthcare providers, treatment centers, and other laboratories, ensuring a comprehensive approach to both the cannabis and healthcare industries.

Bioventus LLC is a medical technology company specializing in orthobiologic solutions aimed at enhancing bone healing and managing osteoarthritis. The company offers a range of products, including active healing therapies that support the recovery of bone fractures and alleviate chronic pain associated with osteoarthritis. Its portfolio features injection therapies for osteoarthritic joints, surgical orthobiologics, and bone healing solutions that promote the body’s natural healing processes. Key offerings include the EXOGEN Ultrasound Bone Healing System and various joint fluid therapies. Bioventus is recognized for its innovative and effective products, which adhere to high quality standards and evidence-based practices. Headquartered in Durham, North Carolina, Bioventus employs around 500 people and generates approximately $240 million in annual revenue. The company operates a distribution network to make its products available to healthcare providers. Bioventus was established in 2011, evolving from the Biologics Division of Smith & Nephew.

CoreLab Partners is a biotech company that provides services related to cardio health monitoring and also provides technological support.

NDC is a privately held medical device company headquartered in Fremont, CA, USA. Focused on the medical field, NDC provides manufacturing, research, development, regulatory and technical support on all aspects of Nitinol technology and processing, and is aggressively expanding its capabilities to meet the growing demand for its shape-memory and superelastic Nitinol products.

Blue Sky Biotech, Inc. is a preclinical contract research organization based in Worcester, Massachusetts, specializing in pharmaceutical research and development. The company provides a range of services, including gene cloning, protein expression, protein purification, and assay development. As a trusted partner to nine of the top ten pharmaceutical companies, Blue Sky Biotech has established a strong reputation in the industry for enhancing productivity in early discovery biology processes. By alleviating the labor-intensive tasks associated with scientific research, Blue Sky enables scientists to focus on key experimentation and innovative theory exploration. Through its commitment to improving the efficiency of the drug discovery process, Blue Sky Biotech contributes to advancements that aim to extend human lifespan and promote overall health.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Bako Integrated Physician Solutions is the premier provider of diagnostic and therapeutic services focusing on the skin, soft tissue and bone of the lower extremity. Their pathology team provides not just information, but also intelligence to enable better patient care.

Signature Genomic Laboratories, based in Spokane, Washington, specializes in molecular cytogenetic diagnostic services. The company offers a range of diagnostic testing for both pediatric and adult patients, as well as prenatal testing services. Its offerings include fluorescence in situ hybridization (FISH) analysis of clinically relevant genetic loci, interpretation of genome microarrays, and G-banded karyotype analysis. By providing comprehensive genetic testing and analysis, Signature Genomic Laboratories aims to support clinicians in diagnosing genetic conditions and informing patient care.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Agilux Laboratories is a contract research organization. The company offers a range of services supporting discovery, pre-clinical, and clinical services. It provides a range of drug metabolism and pharmacokinetic services for biotech and pharmaceutical industries. The company’s services include discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and Immunoassays services. It focuses on bioanalytical and PK/PD testing services for the biotech and pharmaceutical industries. Agilux Laboratories was founded by Peter Glick in 2007 and is headquartered in Worcester, Massachusetts.

RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

ChanTest has developed the world's most complete library of validated human ion channel-expressing cell lines to serve all the ion channel needs of its pharmaceutical and biotech customers. Services range from early functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process – to a complete set of in vitro GLP service products for cardiac risk assessment. ChanTest works in partnership with customers to speed the drug-development process, save time and money, and ultimately – to help make better, safer drugs.

Cequent Pharmaceuticals is an early-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative RNA interference (RNAi)-based therapeutics to prevent and treat various human diseases, including inflammatory conditions and cancer. The company utilizes its proprietary TransKingdom RNA interference (tkRNAi) technology, designed to safely and effectively deactivate specific genes associated with diseases using non-pathogenic bacteria to deliver RNAi directly into cells. Currently, Cequent's lead drug candidates, which target colon cancer prevention and inflammatory bowel disease, are in pre-clinical development. Established in 2006, Cequent originated from pioneering research at the Institut Pasteur in Paris and the Beth Israel Deaconess Medical Center/Harvard Medical School. In 2010, the company was acquired by Marina Biotech, Inc.

CRI Lifetree operates as a specialized research organization. The Company focuses on the conduct and design of early stage endocrinology and infectious disease research products and services. CRI Lifetree provides clinical research throughout the United States.

Lead poisoning threatens millions of people, yet is entirely preventable. Our mission is to help identify and protect those at risk. Magellan Diagnostics is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services focused on lead testing. Headquartered outside Boston in Billerica, Massachusetts, Magellan is dedicated to offering high-quality, reliable products that help identify children and adults at risk of harm due to lead exposure. Magellan Diagnostics has been a pioneer in the analysis of blood lead since the late 1960s, when the company (then called ESA, Inc.) was founded by four PhD graduates from the Massachusetts Institute of Technology (MIT). Applying a novel technique called Anodic Stripping Voltammetry (ASV), they designed and built a bench top analyzer for the measurement of lead in blood. The company then adapted this technology to create smaller, portable instruments that can be used outside of the traditional reference laboratory. This major achievement broadened the accessibility of lead testing by bringing it to the point of care.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Ortho Organizers, a full-line manufacturer and distributor of orthodontics products.

RadPharm provides radiopharmaceutical products to medical practices in Australia. Its product portfolio includes sterile vials, cold kits, contract manufacturing, and more.

Assay Designs, founded in 1992, provides quality, rapid, and easy-to-use products for the worldwide biomedical, pharmaceutical and scientific research communities to "Simplify Your Science®". Thier rapidly expanding product line includes kits and materials for the detection and quantification of molecules that are important in cell regulation, signal transduction, inflammation, oxidative processes and apoptosis. Assay Designs develops, produces and markets CORRELATE™ and TITERZYME® immunoassay kits, detection kits, FLASHLIGHT® and BIOLIGHT™ luminescent compounds, antibodies and miscellaneous compounds. Providing unsurpassed precision and reproducibility, Assay Designs offers a broad range of eicosanoid kits and human and mouse cytokine kits and the world's only non-radioactive COX activity kit. In addition, a wide selection of related antigen and antibody products are available to meet your specific research needs. Assay Designs also offers contract manufacturing and custom design products for specialized research needs.

Medifacts International, Inc. specializes in cardiovascular safety monitoring services tailored for the pharmaceutical and biotech sectors. Founded in 1985 and headquartered in Rockville, Maryland, with additional offices in Germany and China, the company offers a range of services, including electrocardiogram (ECG) services, digital Holter monitoring, ambulatory blood pressure monitoring, and telemedicine. It also provides consulting and medical writing services, which encompass program and protocol design, statistical analysis, regulatory guidance, and expert reporting for clinical trials. Moreover, Medifacts International delivers medical imaging services and education seminars, enhancing its offerings in cardiac safety and patient monitoring. The company was acquired by CoreLab Partners in 2010.

ProGene Biomedical is a clinical reference laboratory specializing in clinical immunology and allergy testing.

Endeca provides enterprise search for large companies including Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company specializes in guided search, auto-categorizing results based on the keywords someone enters. Endeca charges from $100,000 to more than $10 million per installation. Endeca competes with FAST Search & Transfer, which was [acquired](http://www.techcrunch.com/2008/01/08/microsoft-has-announced-a-takeover-bid-for-fast-search-transfer-priced-at-12-billion/) by Microsoft for 1.2 Billion in January 2008.

ESA Bioscience is a company that was acquired by Ampersand Capital Partners in 2004.

Panacos Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of small-molecule oral drugs targeting human immunodeficiency virus (HIV) and other viral diseases. Founded in 1999 and based in Watertown, Massachusetts, the company employs innovative technologies to identify novel targets in the viral life cycle, particularly in areas such as virus maturation and fusion. Its product pipeline includes advanced programs aimed at inhibiting HIV maturation, representing second- and third-generation therapeutic options.

Proficiency, Inc. specializes in product knowledge integration and CAD interoperability solutions, facilitating the sharing of product data among manufacturers and suppliers across various engineering and manufacturing sectors. The company's offerings include product knowledge migration, which provides a structured approach to meet migration requirements, and supplier delivery solutions aimed at original equipment manufacturers and higher-tier suppliers. Key products include Collaboration Gateway V7.0, which allows for the transfer of comprehensive product knowledge between different CAD systems, and Completion Wizard, an interactive tool for managing the completion process. Additionally, Proficiency provides CAD translation services, consulting on migration and supplier delivery strategies, and implementation services such as training and support. The company primarily serves clients in the automotive, aerospace, defense, and heavy machinery industries. Founded in 1998 and based in Marlborough, Massachusetts, Proficiency operates as a subsidiary of ITI TranscenData.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.

FirstRain, Inc. is a developer of a cloud-based business analytics platform that helps Fortune 1000 companies enhance their decision-making processes. Founded in 2000 and headquartered in San Mateo, California, the company offers tailored analytics solutions for sales, marketing, and finance professionals, enabling them to understand their customers' businesses and the broader market landscape. FirstRain employs advanced algorithms to capture and analyze unstructured data from the global web and social media, facilitating the identification of new sales opportunities and lead generation. The platform seamlessly integrates with leading CRM and social enterprise systems, such as Salesforce.com and Microsoft Dynamics, as well as prominent research platforms. FirstRain has additional offices in New York and Gurgaon, India, and operates as a subsidiary of Ignite Technologies, Inc.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.

Viadux is a prominent provider of pipeline products and in-building broadband access solutions catering to the telecommunications and cable industries. The company specializes in delivering high-speed data, video, and voice services to small-to-medium enterprises and residential customers within the Multi-Tenant Unit (MTU/MDU) market. In addition, Viadux manufactures and supplies a variety of pipeline products, including ductile iron pipes, air and water valves, industrial plastics, clamps, couplings, and pipe fittings. This diverse product range allows Viadux to serve municipal, commercial, and industrial clients throughout the Asia Pacific region, positioning the company as a comprehensive provider of critical solutions in both telecommunications and infrastructure sectors.

Endeca provides enterprise search for large companies including Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company specializes in guided search, auto-categorizing results based on the keywords someone enters. Endeca charges from $100,000 to more than $10 million per installation. Endeca competes with FAST Search & Transfer, which was [acquired](http://www.techcrunch.com/2008/01/08/microsoft-has-announced-a-takeover-bid-for-fast-search-transfer-priced-at-12-billion/) by Microsoft for 1.2 Billion in January 2008.

Ensemble Communications is a develops wireless infrastructure equipment for high-speed local broadband access applications.

Cyclis Pharmaceuticals is focused on researching and developing small-molecule drugs aimed at treating cancer. The company employs a novel technology that selectively targets cancer cells while preserving normal cells by restoring and activating cellular checkpoints that are often defective in cancer. This approach is designed to correct apoptotic and cellular checkpoint defects commonly found in cancer cells, leading to higher efficacy and reduced toxicity compared to traditional cancer therapies. Through its innovative methods, Cyclis Pharmaceuticals strives to improve treatment outcomes for cancer patients.

Endeca provides enterprise search for large companies including Borders, Boeing, the Census Bureau, the EPA, Ford, Hallmark, IBM, and Toshiba. The company specializes in guided search, auto-categorizing results based on the keywords someone enters. Endeca charges from $100,000 to more than $10 million per installation. Endeca competes with FAST Search & Transfer, which was [acquired](http://www.techcrunch.com/2008/01/08/microsoft-has-announced-a-takeover-bid-for-fast-search-transfer-priced-at-12-billion/) by Microsoft for 1.2 Billion in January 2008.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Blackstone Technology Group provides software and services that create high throughput computing environments. Blackstone helps customers speed time-to-market by designing and optimizing infrastructures for high user productivity, low administrative burden, and low ownership cost. Blackstone accomplishes these goals with Consultants who have expertise in the applications and process methodologies, as well as in the design and optimization of large-scale, high-throughput computing environments; and Software products that simplify usage and administration of the environment, as well as maximize computing throughput and architecture scalability.

LightPointe Communications, Inc. (a.k.a. LightPointe Wireless) is privately held. The company was launched in 1998 and is headquartered in San Diego, CA, with regional offices/presence in Europe (Germany & France) and Asia (Thailand). LightPointe also provides solutions via its AirePointe Security & Government Solutions Division (www.AirePointe.com). LightPointe is the number one manufacturer in the world of point-to-point Gigabit Ethernet Free Space Optics and Hybrid Optical-Radio Bridges, and manufactures a complete line of 4G/LTE backhaul radios (60 GHz & 70/80 GHz e-band) for telecom carriers and enterprises such as businesses, schools, the military & government agencies. With over $80 million in product development and over eight key patents, LightPointe has deployed thousands of Gigabit Ethernet bridges and digital video/security backhaul solutions worldwide.

Silicon Wave, based in San Diego, is a pioneer in Bluetooth wireless technology and specializes in the design, development, and manufacturing of radio frequency integrated circuits. The company focuses on creating RF systems-on-chip that are utilized in various applications within wireless and broadband communication systems. Through its innovative approach, Silicon Wave contributes to advancements in connectivity and communication technology.